Clinical Trials Browser

Recruiting × Cholangiocarcinoma × sintilimab × Clear all

NCT05010681 2025-02-27

Lenvatinib Plus Sintilimab in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Liver Cancer

Phase 2 Recruiting

Gastrointestinal

Cholangiocarcinoma